CDH1 and invasive breast carcinoma: However, there are conflicting reports about the usefulness of E-cadherin status as an independent prognostic marker in invasive breast cancer (Lipponen et al, 1994; Bukholm et al, 1998; Parker et al, 2001; Howard et al, 2004, 2005).